Strategy and Hypothesis of Molecular Targeted Therapy for Metastatic Colorectal Cancer
10.3969/j.issn.1008-7125.2016.06.001
- VernacularTitle:转移性结直肠癌分子靶向治疗的策略和思考
- Author:
Jiayan CHEN
;
Xi TANG
- Publication Type:Journal Article
- Keywords:
Colorectal Neoplasms;
Neoplasm Metastasis;
Molecular Targeted Therapy;
Vascular Endothelial Growth Factors;
Receptor,Epidermal Growth Factor
- From:
Chinese Journal of Gastroenterology
2016;21(6):321-325
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer is one of the most commonly seen malignant tumors,and the metastatic colorectal cancer is of poor prognosis. The median overall survival for chemotherapy is only 1-1. 5 years. Recently,molecular targeted therapy targeting at vascular endothelial growth factor and epidermal growth factor receptor was used widely for metastatic colorectal cancer and becoming a hot spot of related researches. This article focused on the strategy and hypothesis of molecular targeted therapy for treatment of metastatic colorectal cancer.
